Dissemin is shutting down on January 1st, 2025

Published in

Springer Verlag, Handbook of experimental pharmacology, p. 57-76, 2013

DOI: 10.1007/978-3-7091-1368-4_3

Links

Tools

Export citation

Search in Google Scholar

Sphingolipid metabolism and neutral sphingomyelinases

Book chapter published in 2013 by Michael V. Airola ORCID, Yusuf A. Hannun
This paper is available in a repository.
This paper is available in a repository.

Full text: Download

Green circle
Preprint: archiving allowed
Green circle
Postprint: archiving allowed
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

Sphingolipids are an important class of lipid molecules that play fundamental roles in our cells and body. Beyond a structural role, it is now clearly established that sphingolipids serve as bioactive signaling molecules to regulate diverse processes including inflammatory signaling, cell death, proliferation, and pain sensing. Sphingolipid metabolites have been implicated in the onset and progression of various diseases including cancer, lung disease, diabetes, and lysosomal storage disorders. Here we will review sphingolipid metabolism to introduce basic concepts as well as emerging complexities in sphingolipid function gained from modern technological advances and detailed cell and animal studies. Furthermore, we will discuss the family of neutral sphingomyelinases (N-SMases), which generate ceramide through the hydrolysis of sphingomyelin and are key enzymes in sphingolipid metabolism. Four mammalian N-SMase enzymes have now been identified. Most prominent is nSMase2 with established roles in bone mineralization, exosome formation, and cellular stress responses. Function for the other N-SMases have been more enigmatic and is an area of active investigation. The known properties and potential role(s) of each enzyme will be discussed to help guide to future studies.